Categories Earnings, LATEST, Technology

Intel’s (INTC) Q4 results beat estimates

Intel Corp. (NASDAQ: INTC) topped revenue and earnings estimates for the fourth quarter of 2019, sending shares soaring 6.8% in aftermarket hours on Thursday.

Total revenue grew 8% year-over-year to $20.2 billion, beating forecasts of $19.2 billion.  

Intel topped Q4 2019 revenue and earnings estimates

GAAP net income increased 33% to $6.9 billion and EPS rose 40% to $1.58. Adjusted net income rose 13% to $6.7 billion while adjusted EPS grew 19% to $1.52. Analysts had estimated adjusted EPS of $1.25.

During the quarter, revenues in the DCG segment increased 19%, aided by strong demand from cloud service provider customers and a strong mix of high-performance 2nd-Generation Intel Xeon Scalable processors. Revenues in the IOTG division improved 13% helped by momentum in retail and transportation.

Mobileye revenues jumped 31% year-over-year due to an increase in ADAS adoption. Revenues in NSG was up 10% due to NAND and Intel Optane bit growth. PSG revenue fell 17% year-over-year. Revenues in the CCG segment increased 2% helped by higher modem sales and desktop platform volumes.

For the first quarter of 2020, Intel expects revenue of approx. $19 billion. GAAP EPS is expected to be $1.23 while adjusted EPS is expected to be $1.30. Revenue is expected to be approx. $73.5 billion for the full year of 2020. EPS, on a GAAP basis, is estimated to be $4.71 and, on an adjusted basis, is projected to be $5.00.  

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top